Navigation Links


Sucessfule in Medical Technology

Karo Bio Announces Sucessfule Phase II Results of KB2115

HUDDINGE, Sweden,11-Jun-2007 / Karo Bio (STO:KARO) successful KB2115 Phase II study meets primary objectives. The 12 week proof of concept phase II study with KB2115 in patients with dyslipidemia has been successfully completed. KB2115 is efficacious in LDL lowering and safe with respect to a broad...
Other TagsRotavirusRotavirusSelectiveSelectiveErectileOther Contentsoverloadoverloadoverloadoverloadirritabilityirritabilityperiodperiodperiodperiodperiodperiodperiodperiodperiodperiodirregularirregularirregularirregularirregularirregularirrigationirrigationirrigationirrigationischemiaischemiaischemiaischemiacardiomyopathycardiomyopathycardiomyopathyitchiness